Pathophysiology of typical hemolytic uremic syndrome
- PMID: 20865634
- DOI: 10.1055/s-0030-1262879
Pathophysiology of typical hemolytic uremic syndrome
Abstract
The typical form of hemolytic uremic syndrome (HUS) is associated with enterohemorrhagic ESCHERICHIA COLI (EHEC) infection. The disease process is initiated and perpetuated by interactions between the pathogen or its virulence factors and host cells, as well as the host response. During EHEC-associated HUS, alterations occurring at the intestinal mucosal barrier and in the circulation, as well as on endothelial cells and other target-organ cells, lead to cell activation and/or cytotoxicity, and trigger a prothrombotic state. This review summarizes current knowledge regarding the interactions of the pathogen and its virulence factors with cells in the intestine, bloodstream, kidney, and brain. Mechanisms of bacterial colonization, toxin circulation, and induction of target organ damage are discussed.
© Thieme Medical Publishers.
Similar articles
-
Enterohemorrhagic Escherichia coli O26:H11-Associated Hemolytic Uremic Syndrome: Bacteriology and Clinical Presentation.Semin Thromb Hemost. 2010 Sep;36(6):586-93. doi: 10.1055/s-0030-1262880. Epub 2010 Sep 23. Semin Thromb Hemost. 2010. PMID: 20865635
-
Complement in typical hemolytic uremic syndrome.Semin Thromb Hemost. 2010 Sep;36(6):620-4. doi: 10.1055/s-0030-1262883. Epub 2010 Sep 23. Semin Thromb Hemost. 2010. PMID: 20865638 Review.
-
The role of virulence factors in enterohemorrhagic Escherichia coli (EHEC)--associated hemolytic-uremic syndrome.Semin Thromb Hemost. 2001 Jun;27(3):207-13. doi: 10.1055/s-2001-15250. Semin Thromb Hemost. 2001. PMID: 11446654 Review.
-
[Enterohemorrhagic Escherichia coli and hemolytic-uremic syndrome].Wien Klin Wochenschr. 1997 Sep 19;109(17):669-77. Wien Klin Wochenschr. 1997. PMID: 9381722 Review. German.
-
[Enterohemorrhagic Escherichia coli in hemolytic uremic syndrome in Chilean children. Evaluation of different technics in the diagnosis of the infection].Rev Med Chil. 1995 Jan;123(1):13-22. Rev Med Chil. 1995. PMID: 7569441 Clinical Trial. Spanish.
Cited by
-
Shiga toxin pathogenesis: kidney complications and renal failure.Curr Top Microbiol Immunol. 2012;357:105-36. doi: 10.1007/82_2011_172. Curr Top Microbiol Immunol. 2012. PMID: 21983749 Free PMC article. Review.
-
Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature.Cell Mol Life Sci. 2013 Feb;70(3):425-57. doi: 10.1007/s00018-012-1060-z. Epub 2012 Jul 6. Cell Mol Life Sci. 2013. PMID: 22766973 Free PMC article. Review.
-
Phenotypic and Genotypic Antimicrobial Resistance in Non-O157 Shiga Toxin-Producing Escherichia coli Isolated From Cattle and Swine in Chile.Front Vet Sci. 2020 Jul 10;7:367. doi: 10.3389/fvets.2020.00367. eCollection 2020. Front Vet Sci. 2020. PMID: 32754621 Free PMC article.
-
Role of Shiga/Vero toxins in pathogenesis.Microbiol Spectr. 2014 Jun;2(3):10.1128/microbiolspec.EHEC-0005-2013. doi: 10.1128/microbiolspec.EHEC-0005-2013. Microbiol Spectr. 2014. PMID: 25530918 Free PMC article. Review.
-
Soluble plasma VE-cadherin concentrations are elevated in patients with STEC infection and haemolytic uraemic syndrome: a case-control study.BMJ Open. 2015 Mar 10;5(3):e005659. doi: 10.1136/bmjopen-2014-005659. BMJ Open. 2015. PMID: 25757942 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical